Well......of course TEVA mentioned revasacor in their trials.....because they must legally. To say they mentioned it in their 3rd quarter update as evidence that it's important I don't see it? TEVA was updating the market on their business of which revasacor is a trial they are conducting. To not mention it would be stupid and boarder line unethical/illegal
unless I misunderstood your point?
Bickering, page-12
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
-0.030(1.99%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $3.654M | 2.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4201 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 9955 | 8 |
View Market Depth
| Last trade - 12.12pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |